LAUREN RYAN: Open Payments
NPI 1801138904 · BEAVER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 37 payments from 10 companies in 2025. Trend: 2023 $967 · 2024 $2,394 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $247 |
| Sumitomo Pharma America, Inc. | 13 | $181 |
| Olympus America Inc. | 5 | $103 |
| Janssen Biotech, Inc. | 4 | $78 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $27 |
| IMMUNITYBIO, INC. | 1 | $23 |
| Cumberland Pharmaceuticals, Inc. | 1 | $20 |
| Teleflex LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Axonics, GEMTESA, iTIND System, ERLEADA, JOURNAVX, PROVENGE, ANKTIVA, CALDOLOR.
Industry payments across PA — which companies pay providers there.
